Diversity Plans in Action: How to Boost Inclusivity in Trials Faster and for the Long Term
The Food and Drug Omnibus Reform Act (FDORA) and Food and Drug Administration’s (FDA’s) latest Draft Guidance on Diversity Action Planning underscore a significant shift in the consequences of limited diversity in clinical trials. For leading research sponsors, the operative word has become “action” as the clock is ticking to implement best practices and track measurable progress towards truly representative research. However, the reality of recruiting historically underrepresented community members for clinical trials is that barriers to participation are multifaceted and best practices can be labor-intensive. At times, it may seem impossible for research sponsors to establish sustained engagement with communities at the grassroots level required to achieve affective trust.
Acclinate’s solution is simple: before recruitment, build representation. With the mission of empowering communities to take action for better health, Acclinate has engaged 100,000+ community members on its NOWINCLUDED platform with a comprehensive library of scroll-stopping digital content, a robust network of activation partners, and the dynamic curation of relevant opportunities to participate in clinical research. In this session, you’ll hear from Acclinate CEO, Del Smith, PhD, on:
- The important difference between affective and cognitive trust;
- The power of mobilizing grassroots community networks and local activation partners at scale;
- The critical roles of predictive analytics and AI in driving results for clinical trial diversity.
Explore Additional Assets
Maternal and Fetal Health Case Study
See how Acclinate accessed, engaged, and mobilized BIPOC women of
childbearing age to increase awareness of and openness to clinical research
8 Best Practices for Clinical Trial Diversity
Discover best practices to make studies more representative and plan
more inclusive studies going forward.
Increase Diversity in Trial Participation Today.
Acclinate’s NOWINCLUDED platform leverages a model of affective trust to boost inclusivity in trials faster and for the long term.
